LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 389

Search options

  1. Article ; Online: Skeletal muscle oxygenation and exercise intolerance in hemodialysis: Navigating toward promising horizons?

    Theodorakopoulou, Marieta / Boutou, Afroditi / Sarafidis, Pantelis

    Respiratory physiology & neurobiology

    2024  Volume 323, Page(s) 104238

    MeSH term(s) Muscle, Skeletal/metabolism ; Lung ; Respiratory Physiological Phenomena ; Renal Dialysis ; Exercise Tolerance/physiology ; Oxygen Consumption/physiology
    Language English
    Publishing date 2024-02-20
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 2077867-3
    ISSN 1878-1519 ; 1569-9048
    ISSN (online) 1878-1519
    ISSN 1569-9048
    DOI 10.1016/j.resp.2024.104238
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Letter regarding the article 'Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care'.

    Alexandrou, Maria-Eleni / Sarafidis, Pantelis A

    European journal of heart failure

    2021  Volume 24, Issue 2, Page(s) 399

    MeSH term(s) Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Heart Failure/drug therapy ; Humans ; Hyperkalemia/drug therapy ; Mineralocorticoid Receptor Antagonists/therapeutic use
    Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Mineralocorticoid Receptor Antagonists
    Language English
    Publishing date 2021-12-06
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 1483672-5
    ISSN 1879-0844 ; 1388-9842
    ISSN (online) 1879-0844
    ISSN 1388-9842
    DOI 10.1002/ejhf.2391
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors.

    Fernández-Fernandez, Beatriz / Sarafidis, Pantelis / Soler, Maria José / Ortiz, Alberto

    Clinical kidney journal

    2023  Volume 16, Issue 8, Page(s) 1187–1198

    Abstract: In the EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) trial, empagliflozin reduced cardiorenal outcomes by 28% (hazard ratio 0.72; 95% confidence interval 0.64-0.82; ...

    Abstract In the EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) trial, empagliflozin reduced cardiorenal outcomes by 28% (hazard ratio 0.72; 95% confidence interval 0.64-0.82;
    Language English
    Publishing date 2023-06-16
    Publishing country England
    Document type Editorial
    ZDB-ID 2655800-2
    ISSN 2048-8513 ; 2048-8505
    ISSN (online) 2048-8513
    ISSN 2048-8505
    DOI 10.1093/ckj/sfad082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Hypernatremia and subclinical chronic kidney disease.

    Sarafidis, Pantelis / Ferro, Charles J / Ortiz, Alberto

    European heart journal

    2022  Volume 43, Issue 41, Page(s) 4436–4437

    MeSH term(s) Humans ; Hypernatremia/complications ; Renal Insufficiency, Chronic/complications ; Kidney Failure, Chronic/complications
    Language English
    Publishing date 2022-07-22
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehac367
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Cardiovascular Events with Finerenone in CKD and Diabetes.

    Ortiz, Alberto / Sarafidis, Pantelis / Ferro, Charles J

    The New England journal of medicine

    2022  Volume 386, Issue 16, Page(s) e43

    MeSH term(s) Cardiovascular Diseases/prevention & control ; Diabetes Mellitus/drug therapy ; Diabetic Nephropathies ; Female ; Humans ; Male ; Naphthyridines ; Renal Insufficiency, Chronic/complications
    Chemical Substances Naphthyridines ; finerenone
    Language English
    Publishing date 2022-04-20
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2200202
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Uromodulin biology.

    Karagiannidis, Artemios G / Theodorakopoulou, Marieta P / Pella, Eva / Sarafidis, Pantelis A / Ortiz, Alberto

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

    2024  

    Abstract: Uromodulin is a kidney-specific glycoprotein which is exclusively produced by the epithelial cells lining the thick ascending limb and early distal convoluted tubule. It is currently recognized as a multifaceted player in kidney physiology and disease, ... ...

    Abstract Uromodulin is a kidney-specific glycoprotein which is exclusively produced by the epithelial cells lining the thick ascending limb and early distal convoluted tubule. It is currently recognized as a multifaceted player in kidney physiology and disease, with discrete roles for intracellular, urinary, interstitial, and serum uromodulin. Among them, uromodulin modulates renal sodium handling through the regulation of tubular sodium transporters that reabsorb sodium and are targeted by diuretics, such as the loop diuretic-sensitive Na+-K+-2Cl- cotransporter type 2 (NKCC2) and the thiazide-sensitive Na+/Cl- cotransporter (NCC). Given these roles, the contribution of uromodulin to sodium-sensitive hypertension has been proposed. However, recent studies in humans suggest a more complex interaction between dietary sodium intake, uromodulin, and blood pressure. This review presents an updated overview of the uromodulin's biology and its various roles and focuses on the interaction between uromodulin and sodium-sensitive hypertension.
    Language English
    Publishing date 2024-01-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 90594-x
    ISSN 1460-2385 ; 0931-0509
    ISSN (online) 1460-2385
    ISSN 0931-0509
    DOI 10.1093/ndt/gfae008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?

    Sarafidis, Pantelis A

    American journal of nephrology

    2017  Volume 46, Issue 4, Page(s) 285–287

    MeSH term(s) Hemodiafiltration ; Humans ; Kidney Failure, Chronic ; Renal Dialysis
    Language English
    Publishing date 2017-11-14
    Publishing country Switzerland
    Document type Editorial ; Comment
    ZDB-ID 604540-6
    ISSN 1421-9670 ; 0250-8095
    ISSN (online) 1421-9670
    ISSN 0250-8095
    DOI 10.1159/000481670
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Lung Ultrasound as a Tool to Evaluate Fluid Accumulation in Dialysis Patients.

    Alexandrou, Maria-Eleni / Theodorakopoulou, Marieta P / Sarafidis, Pantelis A

    Kidney & blood pressure research

    2022  Volume 47, Issue 3, Page(s) 163–176

    Abstract: Background: Volume overload is the main mechanism of BP elevation in end-stage kidney disease (ESKD) patients undergoing hemodialysis or peritoneal dialysis and has been linked to adverse outcomes and increased mortality in this population.: Summary: ...

    Abstract Background: Volume overload is the main mechanism of BP elevation in end-stage kidney disease (ESKD) patients undergoing hemodialysis or peritoneal dialysis and has been linked to adverse outcomes and increased mortality in this population.
    Summary: This review discusses current knowledge on lung ultrasound as a tool for detection of extracellular volume overload through evaluation of extravascular lung water content. We describe the principles of lung US, the main protocols to apply it in clinical practice, and accumulated data evidence regarding its associations with cardiovascular events and mortality. We also summarize available evidence on the effect of lung ultrasound-guided -volume management strategies on BP control, echocardiographic parameters, and major outcomes in patients undergoing dialysis.
    Key messages: Among interventions attempting to reduce the burden of cardiovascular disease in ESKD, effective management of volume overload represents an unmet clinical need. Assessment of hydration status by lung ultrasound is a cheap, easy to employ, and real-time technique that can offer accurate dry weight assessment leading to several clinical benefits.
    MeSH term(s) Humans ; Kidney Failure, Chronic/complications ; Lung/diagnostic imaging ; Peritoneal Dialysis/adverse effects ; Renal Dialysis/adverse effects ; Ultrasonography
    Language English
    Publishing date 2022-01-10
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1326018-2
    ISSN 1423-0143 ; 1420-4096
    ISSN (online) 1423-0143
    ISSN 1420-4096
    DOI 10.1159/000521691
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pregnancy outcomes in ANCA-associated vasculitis patients: A systematic review and meta-analysis.

    Partalidou, Styliani / Mamopoulos, Apostolos / Dimopoulou, Despoina / Sarafidis, Pantelis / Dimitroulas, Theodoros

    Joint bone spine

    2023  Volume 90, Issue 6, Page(s) 105609

    Abstract: Objective: Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV), namely granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis and microscopic polyangiitis constitute a group of rare systemic vasculitides, ... ...

    Abstract Objective: Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV), namely granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis and microscopic polyangiitis constitute a group of rare systemic vasculitides, affecting small vessels. Genders are equally affected, with symptoms most commonly presenting during and/or after the fifth decade of life, but AAV may also present in younger individuals. As advanced maternal age is becoming common and safe over the last decades, it is now more feasible for middle-aged women suffering from AAV to get pregnant. Although adverse pregnancy outcomes have been thoroughly investigated in other systemic diseases, the exact prevalence of pregnancy complications and unfavorable outcomes in pregnant women with AAV has not been systematically evaluated.
    Methods: We researched PubMed, Scopus, Cochrane Library and Cinahl databases until September, 2022. Three blinded investigators extracted data and assessed the risk of bias. A random effects model was used for the analysis. The outcomes studied were pre-term delivery, intrauterine growth restriction (IUGR) neonates and disease flare.
    Results: We included six studies with 92 pregnancies in patients with AAV. The prevalence of pre-term delivery, IUGR neonates and disease flare were 18% (CI: 0.10-0.30, P=non-significant), 20% (CI: 0.11-0.33, P=non-significant) and 28% (CI: 0.09-0.59, P<0.01), respectively.
    Conclusion: The analysis demonstrated higher occurrence of adverse outcomes in pregnant women suffering from AAV accompanied by an increased risk of disease flare during pregnancy. These findings underline the importance of preconception counseling and the necessity of close monitoring in these patients similarly to other systemic inflammatory diseases.
    MeSH term(s) Middle Aged ; Infant, Newborn ; Female ; Humans ; Male ; Pregnancy ; Granulomatosis with Polyangiitis/diagnosis ; Churg-Strauss Syndrome ; Pregnancy Outcome/epidemiology ; Symptom Flare Up ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis ; Antibodies, Antineutrophil Cytoplasmic
    Chemical Substances Antibodies, Antineutrophil Cytoplasmic
    Language English
    Publishing date 2023-07-05
    Publishing country France
    Document type Meta-Analysis ; Systematic Review ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2020487-5
    ISSN 1778-7254 ; 1297-319X
    ISSN (online) 1778-7254
    ISSN 1297-319X
    DOI 10.1016/j.jbspin.2023.105609
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: SGLT-2 Inhibitors and Nephroprotection in Patients with Diabetic and Non-diabetic Chronic Kidney Disease.

    Sarafidis, Pantelis / Pella, Eva / Kanbay, Mehmet / Papagianni, Aikaterini

    Current medicinal chemistry

    2022  Volume 30, Issue 18, Page(s) 2039–2060

    Abstract: For several years, blood pressure control and blocking of the renin-angiotensin system (RAS) represented the cornerstones of chronic kidney disease (CKD) treatment. Cardiovascular outcome trials with sodium-glucose co-transporter-2 (SGLT-2) inhibitors in ...

    Abstract For several years, blood pressure control and blocking of the renin-angiotensin system (RAS) represented the cornerstones of chronic kidney disease (CKD) treatment. Cardiovascular outcome trials with sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients with type 2 diabetes mellitus (DM) suggested that these agents can effectively delay the progression of CKD in these individuals. A major nephroprotective effect of canagliflozin was also shown in a renal outcome trial in patients with proteinuric diabetic CKD. The Study-to- Evaluate-the-Effect- of-Dapagliflozin-on-Renal-Outcomes-and-Cardiovascular- Mortality-in-Patients-With-Chronic-Kidney-Disease (DAPA-CKD) is a recent milestone in the field, as it included patients with both diabetic and non-diabetic proteinuric CKD and showed impressive reduction in the primary renal outcome of CKD progression, as well as the risk of hospitalization for heart failure and all-cause mortality on top of standard- of-care treatment. These benefits were consistent for patients with diabetic and non-diabetic CKD, including patients with ischemic or hypertensive nephropathy and glomerulonephritides (IgA nephropathy, focal segmental glomerulosclerosis and membranous nephropathy). Based on the above, relevant guidelines should accommodate their recommendations to implement treatment with SGLT-2 inhibitors for CKD patients.
    MeSH term(s) Humans ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Hypoglycemic Agents ; Cardiovascular Diseases/complications ; Diabetic Nephropathies/etiology ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/drug therapy
    Chemical Substances Sodium-Glucose Transporter 2 Inhibitors ; Hypoglycemic Agents
    Language English
    Publishing date 2022-08-27
    Publishing country United Arab Emirates
    Document type Journal Article
    ZDB-ID 1319315-6
    ISSN 1875-533X ; 0929-8673
    ISSN (online) 1875-533X
    ISSN 0929-8673
    DOI 10.2174/0929867329666220825121304
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top